Number of the records: 1
HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study
SYS 0482175 LBL 01000a^^22220027750^450 005 20240103215034.5 014 $a 85035026360 $2 SCOPUS 014 $a 29133205 $2 PUBMED 014 $a 000424259100011 $2 WOS 017 $a 10.1016/j.ijpharm.2017.11.011 $2 DOI 100 $a 20171128d m y slo 03 ba 101 $a eng 102 $a GB 200 1-
$a HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study 215 $a 8 s. 463 -1
$1 001 cav_un_epca*0256810 $1 011 $a 0378-5173 $e 1873-3476 $1 200 1 $a International Journal of Pharmaceutics $v Roč. 536, č. 1 (2018), s. 108-115 $1 210 $c Elsevier 610 $a EPR effect 610 $a HPMA copolymer 610 $a tumor-targeting 700 -1
$3 cav_un_auth*0354059 $4 070 $a Islam $b W. $y JP 701 -1
$3 cav_un_auth*0288458 $4 070 $a Fang $b J. $y JP $z K 701 -1
$3 cav_un_auth*0103021 $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $a Etrych $b Tomáš $p UMCH-V $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0103004 $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $a Chytil $b Petr $p UMCH-V $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0103208 $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $a Ulbrich $b Karel $p UMCH-V $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0354060 $4 070 $a Sakoguchi $b A. $y JP 701 -1
$3 cav_un_auth*0354061 $4 070 $a Kusakabe $b K. $y JP 701 -1
$3 cav_un_auth*0050149 $4 070 $a Maeda $b H. $y JP $z K
Number of the records: 1